NVZMY vs. NOVO-B.CO
Compare and contrast key facts about Novozymes AS (NVZMY) and Novo Nordisk A/S (NOVO-B.CO).
Performance
NVZMY vs. NOVO-B.CO - Performance Comparison
Loading graphics...
NVZMY vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVZMY Novozymes AS | -4.43% | 14.29% | 3.97% | 12.42% | -38.46% | 46.93% | 18.10% | 10.28% | -20.91% | 69.59% |
NOVO-B.CO Novo Nordisk A/S | -25.78% | -39.54% | -15.04% | 55.49% | 22.06% | 62.19% | 24.39% | 29.71% | -12.97% | 54.02% |
Different Trading Currencies
NVZMY is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, NVZMY achieves a -4.43% return, which is significantly higher than NOVO-B.CO's -25.78% return. Over the past 10 years, NVZMY has underperformed NOVO-B.CO with an annualized return of 4.60%, while NOVO-B.CO has yielded a comparatively higher 5.41% annualized return.
NVZMY
- 1D
- 0.53%
- 1M
- 4.83%
- YTD
- -4.43%
- 6M
- -1.80%
- 1Y
- 5.95%
- 3Y*
- 7.39%
- 5Y*
- 0.29%
- 10Y*
- 4.60%
NOVO-B.CO
- 1D
- 2.84%
- 1M
- 2.36%
- YTD
- -25.78%
- 6M
- -34.10%
- 1Y
- -44.56%
- 3Y*
- -20.52%
- 5Y*
- 3.75%
- 10Y*
- 5.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVZMY vs. NOVO-B.CO — Risk / Return Rank
NVZMY
NOVO-B.CO
NVZMY vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novozymes AS (NVZMY) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVZMY | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.22 | -0.79 | +1.01 |
Sortino ratioReturn per unit of downside risk | 0.51 | -0.93 | +1.44 |
Omega ratioGain probability vs. loss probability | 1.06 | 0.87 | +0.19 |
Calmar ratioReturn relative to maximum drawdown | 0.19 | -0.80 | +0.99 |
Martin ratioReturn relative to average drawdown | 0.38 | -1.39 | +1.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NVZMY | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.22 | -0.79 | +1.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | 0.10 | -0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.17 | 0.16 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.07 | 0.43 | -0.50 |
Correlation
The correlation between NVZMY and NOVO-B.CO is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
NVZMY vs. NOVO-B.CO - Dividend Comparison
NVZMY's dividend yield for the trailing twelve months is around 2.71%, less than NOVO-B.CO's 4.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVZMY Novozymes AS | 2.71% | 1.51% | 1.03% | 2.68% | 1.68% | 0.69% | 0.91% | 1.03% | 1.10% | 1.64% | 0.95% | 0.60% |
NOVO-B.CO Novo Nordisk A/S | 4.94% | 3.58% | 1.59% | 1.01% | 1.19% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% |
Drawdowns
NVZMY vs. NOVO-B.CO - Drawdown Comparison
The maximum NVZMY drawdown since its inception was -86.29%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for NVZMY and NOVO-B.CO.
Loading graphics...
Drawdown Indicators
| NVZMY | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.29% | -76.75% | -9.54% |
Max Drawdown (1Y)Largest decline over 1 year | -29.64% | -54.94% | +25.30% |
Max Drawdown (5Y)Largest decline over 5 years | -51.86% | -76.75% | +24.89% |
Max Drawdown (10Y)Largest decline over 10 years | -51.86% | -76.75% | +24.89% |
Current DrawdownCurrent decline from peak | -58.86% | -75.38% | +16.52% |
Average DrawdownAverage peak-to-trough decline | -57.40% | -15.80% | -41.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.99% | 32.14% | -17.15% |
Volatility
NVZMY vs. NOVO-B.CO - Volatility Comparison
The current volatility for Novozymes AS (NVZMY) is 8.01%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 9.70%. This indicates that NVZMY experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NVZMY | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.01% | 9.70% | -1.69% |
Volatility (6M)Calculated over the trailing 6-month period | 18.93% | 41.71% | -22.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.15% | 57.00% | -29.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.79% | 39.06% | -11.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.20% | 33.04% | -5.84% |
Financials
NVZMY vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Novozymes AS and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities